HCA Healthcare Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Core Insights - HCA Healthcare Inc. reported strong third-quarter 2025 financial results with total revenues of $19.16 billion, a 9.6% year-over-year increase, exceeding the consensus estimate of $18.57 billion [1] - Adjusted earnings for the quarter were $6.96, up from $4.90 a year ago, surpassing the consensus of $5.72 [1] Financial Guidance - HCA Healthcare raised its fiscal year 2025 guidance from $25.50 to $27 to a new range of $27 to $28, exceeding the consensus of $26.33 [2] - The 2025 sales guidance was revised from $74 billion to $76 billion to a new range of $75 billion to $76.5 billion, compared to the consensus of $75.02 billion [3] - The forecast for 2025 net income was updated to $6.495 billion-$6.715 billion, compared to prior guidance of $6.11 billion-$6.48 billion [3] Stock Performance - Following the earnings announcement, HCA Healthcare shares rose 1.3% to trade at $452.66 [3] - Analysts adjusted their price targets for HCA Healthcare, with several maintaining positive ratings and increasing targets [5] Analyst Ratings - Keybanc analyst maintained an Overweight rating and raised the price target from $465 to $475 [5] - Mizuho analyst maintained an Outperform rating and raised the price target from $475 to $505 [5] - Truist Securities analyst maintained a Buy rating and raised the price target from $460 to $495 [5] - Stephens & Co. analyst maintained an Overweight rating and raised the price target from $450 to $500 [5]